CBD is often a CB1 antagonist by using a weak affinity with the CB1 receptor, indicating it doesn’t bind pretty strongly. From a pharmacological point of view, it’s very similar to THC, as well as really restricted analysis that's been finished on it indicates it's got equivalent consequences, just with https://thcdisposables.co.uk/